NASDAQ · CHEK
Healthcare · Medical - Diagnostics & Research
$1.86
Up+$0.03 (+1.64%)
Updated Sep 11, 2026, 7:42 AM
SID Score
—
Composite research score
Smart Money
—
Institutional and insider signal
Price performance
1M range · 0 trading sessions · Daily adjusted prices
CHEK does not have enough price history for the selected period.
Data unavailable
The requested market data was not found.
The latest Smart Investors Daily articles mentioning CHEK.
CHEK research
Company profile and research snapshot.
Check-Cap Ltd., a clinical stage medical diagnostics company, engages in the development of a capsule-based screening technology that utilizes ultra-low-dose X-rays to scan the inner lining of the colon for precancerous polyps, and other structural abnormalities in Israel. Its C-Scan system consists of C-Scan Cap, an X-ray scanning capsule for detection of suspected polyps; C-Scan Track, a disposable system attached to the patient's back through biocompatible adhesive skin patches; and C-Scan View software, a client/server-based application that enables procedure data download from the C-Scan Track, data analysis, and report generation. The company was incorporated in 2004 and is based in Isfiya, Israel.
Visit company websiteConsensus and target data currently published for this company.
| Date | Firm | Rating | Target |
|---|---|---|---|
| Jun 7, 2023 | HC Wainwright & Co. | Neutral | — |
| May 15, 2023 | HC Wainwright & Co. | Buy | — |
| Apr 5, 2023 | HC Wainwright & Co. | Buy | — |
| Aug 9, 2021 | HC Wainwright & Co. | Buy | — |
| Mar 17, 2021 | Dawson James | Neutral | — |
No generated briefing is available yet.
newsfilecorp.com · Nov 17, 2025
Nasdaq-listed AI company gains overwhelming shareholder support for its transformational merger, positioning MBody AI ($CHEK) as a hardware-agnostic embodied intelligence leader ready to scale enterprise automation. Las Vegas, Nevada and Isfiya, Isreal--(Newsfile Corp. - November 17, 2025) - MBody AI Corp. ("MBody AI") and Check-Cap Ltd.
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
The latest Smart Investors Daily articles mentioning CHEK.
No results
No recent SID articles mention CHEK.
